Other
Net Change in Cash
Alnylam Pharmaceuticals Net Change in Cash decreased by 67.7% to $53.61M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.0%, from $53.60M to $53.61M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ4 2016
Last reportedQ4 2025
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
Metric ID:
net_change_in_cashHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $366.06M | $348.39M | -$285.89M | $41.48M | $497.65M | -$194.15M | -$14.44M | $375.23M | -$220.33M | -$130.17M | $286.47M | $131.31M | $53.60M | $93.61M | $376.94M | $166.01M | $53.61M |
| QoQ Change | — | -4.8% | -182.1% | +114.5% | >999% | -139.0% | +92.6% | >999% | -158.7% | +40.9% | +320.1% | -54.2% | -59.2% | +74.7% | +302.7% | -56.0% | -67.7% |
| YoY Change | — | — | — | -88.7% | +42.8% | +32.1% | -134.8% | -24.6% | — | +33.0% | >999% | -65.0% | +141.2% | -67.3% | +187.1% | — | +0.0% |
Range-$285.89M – $497.65M
CAGR-38.1%
Avg YoY Growth+178.4%
Median YoY Growth+16.1%
Current Streak2 quarters decline
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's net change in cash?
- Alnylam Pharmaceuticals (ALNY) reported net change in cash of $53.61M in Q1 2026.
- How has Alnylam Pharmaceuticals's net change in cash changed year-over-year?
- Alnylam Pharmaceuticals's net change in cash increased by 0.0% year-over-year, from $53.60M to $53.61M.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.